Free database of papers and journals

Results 1 to 20 of 66 articles found

Hydroxychloroquine concentration–response relationships in patients with rheumatoid arthritis

Arthritis and Rheumatism (365), 46, 1460-1469.

Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: A randomized, double-blind six-week trial with eighteen-week extension

Arthritis and Rheumatism (365), 42, 357-365.

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis

Arthritis and Rheumatism (365), 59, 762-784.

[Review] A Clinical and Economic Review of Disease-Modifying Antirheumatic Drugs

PharmacoEconomics (4 105), 19, 715-728.

Improvement of High-Density Lipoprotein Function in Patients With Early Rheumatoid Arthritis Treated With Methotrexate Monotherapy or Combination Therapies in a Randomized Controlled Trial

Arthritis & Rheumatology (6.4 108), 69, 46-57.

Serum cotinine as a biomarker of tobacco exposure and the association with treatment response in early rheumatoid arthritis

Arthritis Care & Research (3.9 106), 64, 1804-1810.

A Novel Method to Combine Assessment of Benefit and Harm: Outcome Measures in Rheumatology 3×3 Methodology Applied to Two Active Comparator Trials

Arthritis Care & Research (3.9 106), 71, 319-322.

Cost-Effectiveness of Triple Therapy Versus Etanercept Plus Methotrexate in Early Aggressive Rheumatoid Arthritis

Arthritis Care & Research (3.9 106), 68, 1751-1757.

2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

Arthritis Care & Research (3.9 106), 64, 625-639.

Clinical Response Within 12 Weeks as a Predictor of Future Low Disease Activity in Patients with Early RA: Results from the TEAR Trial

Journal of Rheumatology (2.7 98), 40, 572-578.

[Communication] Comment on the article by Furst et al

Arthritis and Rheumatism (365), 32, 1631-1632.

Genetic variants associated with methotrexate efficacy and toxicity in early rheumatoid arthritis: results from the treatment of early aggressive rheumatoid arthritis trial

Pharmacogenomics Journal (3.1 87★★), 14, 48-53.

Etanercept Therapy in Rheumatoid Arthritis

Annals of Internal Medicine (3.1 435★★★), 130, 478.

Acute febrile neutrophilic dermatosis (sweet syndrome): A review of the literature with emphasis on musculoskeletal manifestations

Seminars in Arthritis and Rheumatism (5 138), 17, 143-155.

Associations of Alcohol Use with Radiographic Disease Progression in African Americans with Recent-onset Rheumatoid Arthritis

Journal of Rheumatology (2.7 98), 40, 1498-1504.

Arthritis Research & Therapy (4.2 134), 7, S2.

Treatment of refractory rheumatoid arthritis with a chimeric ANTI-CD4 monoclonal antibody

Arthritis and Rheumatism (365), 37, 834-838.

Clinical therapeutics for musculoskeletal disorders: what??s working and what??s not working


Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: Results of a twenty-four–week, multicenter, randomized, double-blind, placebo-controlled trial

Arthritis and Rheumatism (365), 46, 614-624.

A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The Treatment of Early Aggressive Rheumatoid Arthritis trial

Arthritis and Rheumatism (365), 64, 2824-2835.
Anatomy of Results
The left numbers are the publication year, and the number of citations (hyperlink to the full citation report of the paper)
paranthesis after the journal provides its impact factor.
paranthesis after the author indicates the number of publications and Author's Impact Factor